NO20075218L - Dermatological compositions and salts for the treatment of dermatological diseases - Google Patents

Dermatological compositions and salts for the treatment of dermatological diseases

Info

Publication number
NO20075218L
NO20075218L NO20075218A NO20075218A NO20075218L NO 20075218 L NO20075218 L NO 20075218L NO 20075218 A NO20075218 A NO 20075218A NO 20075218 A NO20075218 A NO 20075218A NO 20075218 L NO20075218 L NO 20075218L
Authority
NO
Norway
Prior art keywords
dermatological
treatment
salts
compositions
diseases
Prior art date
Application number
NO20075218A
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Astion Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Pharma As filed Critical Astion Pharma As
Publication of NO20075218L publication Critical patent/NO20075218L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører dermatologiske sammensetninger av Oxaprozin eller en nært beslektet forbindelse tilpasset for behandling av en dermatologisk sykdom, hvori minst to av enzymene valgt fra protein-tyrosinkinase Syk, protein-tyrosinkinase ZAP-70 og fosfodiestrase IV spiller en rolle i medieringen av den dermatologiske sykdommen. Oppfinnelsen omfatter også dermatologiske sammensetninger for behandlingen av pruritus.
NO20075218A 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases NO20075218L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200500437 2005-03-30
DKPA200500438 2005-03-30
US69477405P 2005-06-27 2005-06-27
DKPA200500949 2005-06-27
DKPA200500948 2005-06-27
US69504005P 2005-06-28 2005-06-28
PCT/DK2006/000181 WO2006102900A1 (en) 2005-03-30 2006-03-30 Dermatological compositions and salts for the treatment of dermatological diseases

Publications (1)

Publication Number Publication Date
NO20075218L true NO20075218L (no) 2007-12-27

Family

ID=36215671

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20075199A NO20075199L (no) 2005-03-30 2007-10-11 Treatment or prevention of pruritus
NO20075218A NO20075218L (no) 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20075199A NO20075199L (no) 2005-03-30 2007-10-11 Treatment or prevention of pruritus

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas

Country Status (12)

Country Link
EP (3) EP1707199A1 (no)
JP (3) JP2008534528A (no)
KR (3) KR20080005525A (no)
AU (3) AU2006228869A1 (no)
BR (3) BRPI0609535A2 (no)
CA (3) CA2603297A1 (no)
EA (3) EA200702027A1 (no)
EC (3) ECSP077843A (no)
IL (3) IL186022A0 (no)
MX (3) MX2007012052A (no)
NO (3) NO20075199L (no)
WO (3) WO2006102899A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821537D0 (en) * 2008-11-25 2008-12-31 Union Life Sciences Ltd Therapeutic target
US20190046481A1 (en) * 2015-09-18 2019-02-14 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
WO2018031529A1 (en) * 2016-08-08 2018-02-15 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
EP3532049A1 (en) 2016-10-25 2019-09-04 Ticure Ltd. Fabp4 as a therapeutic target in skin diseases
KR20200097297A (ko) * 2017-12-07 2020-08-18 더마반트 사이언시즈 게엠베하 Pde-4 억제제의 국소 연고 제형 및 피부 병태 치료에서의 이의 용도
RU2685436C1 (ru) * 2018-06-22 2019-04-18 ЗАО "ФармФирма "Сотекс" Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP7514598B2 (ja) * 2018-12-20 2024-07-11 小林製薬株式会社 皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
SK48896A3 (en) 1993-10-20 1997-03-05 Boots Co Plc Application of ibuprofen and flurbiprofen as anti-pruritic agents and and pharmaceutical compositions for this use
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
GB9606429D0 (en) 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
DE69733752T2 (de) * 1996-05-20 2006-06-01 G.D. Searle Llc, Chicago Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en) 2004-04-14 2005-10-20 Katz Kenneth A Compositions and methods for moisturizing skin

Also Published As

Publication number Publication date
WO2006102898A2 (en) 2006-10-05
CA2605121A1 (en) 2006-10-05
ECSP077843A (es) 2008-02-20
EP1707201A1 (en) 2006-10-04
CA2603300A1 (en) 2006-10-05
KR20080011280A (ko) 2008-02-01
WO2006102898A3 (en) 2006-12-28
AU2006228869A1 (en) 2006-10-05
WO2006102899A3 (en) 2006-12-28
EP1707199A1 (en) 2006-10-04
NO20075199L (no) 2008-01-02
CA2603297A1 (en) 2006-10-05
IL186022A0 (en) 2008-02-09
WO2006102899A2 (en) 2006-10-05
EA200702027A1 (ru) 2008-02-28
KR20080005526A (ko) 2008-01-14
AU2006228871A1 (en) 2006-10-05
AU2006228870A1 (en) 2006-10-05
EA200702023A1 (ru) 2008-04-28
MX2007012051A (es) 2008-02-22
NO20075227L (no) 2007-12-09
IL186020A0 (en) 2008-01-20
WO2006102900A1 (en) 2006-10-05
ECSP077845A (es) 2008-02-20
MX2007012052A (es) 2008-02-22
JP2008534526A (ja) 2008-08-28
IL186021A0 (en) 2008-02-09
ECSP077846A (es) 2008-02-20
EA200702026A1 (ru) 2008-04-28
JP2008534528A (ja) 2008-08-28
KR20080005525A (ko) 2008-01-14
BRPI0607648A2 (pt) 2009-09-22
EP1707200A1 (en) 2006-10-04
BRPI0609653A2 (pt) 2010-04-20
MX2007012050A (es) 2008-03-11
BRPI0609535A2 (pt) 2010-04-13
JP2008534527A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
NO20075218L (no) Dermatological compositions and salts for the treatment of dermatological diseases
WO2007027238A3 (en) Jak kinase inhibitors and their uses
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
TW200714604A (en) Substituted heterocycles and the uses thereof
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
WO2009006389A3 (en) Pyrimidine derivatives useful as raf kinase inhibitors
HK1131612A1 (en) Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
MX2009012066A (es) Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
TW200734327A (en) Aminopyrimidines useful as kinase inhibitors
NO20085176L (no) Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter
WO2007011833A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
CL2007002836A1 (es) Compuestos derivados de 1,3,5-triazina o pirimidina, inhibidores de quinasa; composicion farmaceutica; y uso para tratar una enfermedad mediada por quinasa, tal como cancer.
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
DK2004641T3 (da) HIV-inhiberende 5-(hydroxymethylen og aminomethylen) substituerede pyrimidiner
GEP20125643B (en) Aurora kinase modulators and method of using same
WO2007109783A3 (en) Substituted pyrimidine kinase inhibitors
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
WO2007081630A3 (en) Substituted pyrimidinyl kinase inhibitors
NO20075749L (no) 1H-Quinazoline-2,4-diones and their use as ampa-receptor ligands
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment
WO2006057945A3 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
MX2009011059A (es) Aminopirimidinas utiles como inhibidores de cinasas.
WO2007058862A3 (en) Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007064753A3 (en) Cancer treatment method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application